Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioavailability, safety, tolerability and
pharmacokinetics of two tablet formulations as compared to the capsule formulation suspended
in liquid.